Damora Therapeutics, Inc. (DMRA) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $3.98 | +121.5% |
| 2024 | $-18.53 | +48.6% |
| 2023 | $-36.08 | -1384.8% |
| 2022 | $-2.43 | -18.5% |
| 2021 | $-2.05 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $3.98 | +121.5% |
| 2024 | $-18.53 | +48.6% |
| 2023 | $-36.08 | -1384.8% |
| 2022 | $-2.43 | -18.5% |
| 2021 | $-2.05 | — |